Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents?

doi:10.5527/wjn.v10.i4.47

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6213)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

358

WORD

173

HTML

2300

Figures (1-2)

279

Tables (1-2)

211

Sum=3321

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

423

Download

923

Sum=1346

Publishing Process of This Article

Item

Count

Browse

485

Download

1061

Sum=1546

Jul 25, 2021 (publication date) through Sep 2, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Nephrol. Jul 25, 2021; 10(4): 47-58
Published online Jul 25, 2021. doi: 10.5527/wjn.v10.i4.47

Open in New Tab Full Size Figure Download Figure

Figure 1 Study protocol for children and adolescents with idiopathic hypercalciuria. IH: Idiopathic hypercalciuria.

Open in New Tab Full Size Figure Download Figure

Figure 2 Comparison of the lumbar spine bone mineral density z-score between Group 1 and Group 2 before and after treatment. Test: U-test Mann-Whitney. BMD: Bone mineral density; HCTZ: Hydrochlorothiazide.

Citation: Penido MGMG, Tavares MS. Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents? World J Nephrol 2021; 10(4): 47-58
URL: https://www.wjgnet.com/2220-6124/full/v10/i4/47.htm
DOI: https://dx.doi.org/10.5527/wjn.v10.i4.47